US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 3.200
- +0.080+2.56%
Close Sep 26 16:00 ET
- 3.210
- +0.010+0.31%
Post 19:24 ET
217.86MMarket Cap-1300P/E (TTM)
3.230High3.094Low872.97KVolume3.130Open3.120Pre Close2.75MTurnover1.87%Turnover Ratio4.57P/E (Static)68.08MShares19.94952wk High0.83P/B149.50MFloat Cap1.57552wk Low--Dividend TTM46.72MShs Float41.930Historical High--Div YieldTTM4.36%Amplitude1.575Historical Low3.155Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Amylyx Pharmaceuticals Stock Forum
Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for Amx0035 for the Treatment of Wolfram Syndrome
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has recently announced the acquisition of avexitide from Eiger BioPharmaceuticals, Inc. Avexitide has already garnered considerable attention for its potential therapeutic benefits and has received designations from the U.S. Food and Drug Administration (FDA). This article delve...
No comment yet